Vitamin D analogs: therapeutic applications and mechanisms for selectivity.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Aspects of Medicine

• Publication date

  2008-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mam.2008.04.001PMID 18554710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D

  2016cited by this paper
• Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity

  2008cited by this paper
• Molecular basis of the potential of vitamin D to prevent cancer

  2008cited by this paper
• Selective inhibition of cyclooxygenase‐2 (COX‐2) by 1α,25‐dihydroxy‐16‐ene‐23‐yne‐vitamin D3, a less calcemic vitamin D analog

  2008cited by this paper
• 19-nor-1α,25-Dihydroxyvitamin D2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo

  2008cited by this paper
• Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.

  2007cited by this paper
• ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects.

  2007cited by this paper
• Differential Effects of Vitamin D Analogs on Vascular Calcification

  2007cited by this paper
• Selective vitamin D receptor modulators and their effects on colorectal tumor growth.

  2007cited by this paper
• Drug Insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease

  2007cited by this paper
• Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs.

  2007cited by this paper
• Novel insights in the immune function of the vitamin D system: synergism with interferon-beta.

  2007cited by this paper
• A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.

  2007cited by this paper
• PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification

  2007cited by this paper
• Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol).

  2007cited by this paper
• Differential recruitment of coactivators to the vitamin D receptor transcriptional complex by 1alpha,25-dihydroxyvitamin D3 analogs.

  2007cited by this paper
• Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)

  2007cited by this paper
• Effect of 2‐Methylene‐19‐nor‐(20S)‐1α‐Hydroxy‐Bishomopregnacalciferol (2MbisP), an Analog of Vitamin D, on Secondary Hyperparathyroidism

  2007cited by this paper
• Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.

  2007cited by this paper
• Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.

  2007cited by this paper
• 1 α-Hydroxyvitamin D2 inhibits growth of human neuroblastoma

  2007cited by this paper
• 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma.

  2007cited by this paper
• Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3.

  2007cited by this paper
• Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1alpha,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity.

  2007cited by this paper
• In vivo relevance for photoprotection by the vitamin D rapid response pathway.

  2007cited by this paper
• The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems.

  2007cited by this paper
• Effects of 22‐Oxacalcitriol and Calcitriol on PTH Secretion and Bone Mineral Metabolism in a Crossover Trial in Hemodialysis Patients With Secondary Hyperparathyroidism

  2007cited by this paper
• Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.

  2007cited by this paper
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

  2007cited by this paper
• Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

  2007cited by this paper
• Epigenetic Silencing of CYP24 in Tumor-derived Endothelial Cells Contributes to Selective Growth Inhibition by Calcitriol*

  2007cited by this paper
• Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification

  2006cited by this paper
• The novel vitamin D analog ZK191784 as an intestine‐ specific vitamin D antagonist

  2006cited by this paper
• Anticancer effects of the novel 1α, 25‐dihydroxyvitamin D3 hybrid analog QW1624F2‐2 in human neuroblastoma

  2006cited by this paper
• Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002

  2006cited by this paper
• Lack of recovery from bone loss 12 months after discontinuation of GnRH agonist goserelin

  2006cited by this paper
• Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery

  2006cited by this paper
• Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.

  2006cited by this paper
• Culture serum-induced conversion from agonist to antagonist of a Vitamin D analog, TEI-9647.

  2006cited by this paper
• Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

  2006cited by this paper
• Vitamin D receptor is a novel drug target for ovarian cancer treatment.

  2006cited by this paper
• Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia

  2006cited by this paper
• Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

  2006cited by this paper
• Fibroblast growth factor 23: the making of a hormone.

  2006cited by this paper
• Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.

  2006cited by this paper
• Ligand binding domain of vitamin D receptors.

  2006cited by this paper
• Mortality risk among hemodialysis patients receiving different vitamin D analogs.

  2006cited by this paper
• 2MD, a new anabolic agent for osteoporosis treatment

  2006cited by this paper
• Faculty Opinions recommendation of Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

  2006cited by this paper
• Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.

  2006cited by this paper
• Prevention of chronic allograft rejection by Vitamin D receptor agonists.

  2005cited by this paper
• Intervention in autoimmunity: the potential of vitamin D receptor agonists.

  2005cited by this paper
• 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.

  2005cited by this paper
• Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.

  2005cited by this paper
• A New Vitamin D Analog, 2MD, Restores Trabecular and Cortical Bone Mass and Strength in Ovariectomized Rats With Established Osteopenia

  2005cited by this paper
• Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform.

  2005cited by this paper
• Inhibition of Parathyroid Hormone: A Dose Equivalency Study of Paricalcitol and Doxercalciferol

  2005cited by this paper
• Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.

  2005cited by this paper
• Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death

  2005cited by this paper
• 19-Nor-1-a-25-Dihydroxyvitamin D2 (Paricalcitol) Safely and Effectively Reduces the Levels of Intact Parathyroid Hormone in Patients on Hemodialysis

  2005cited by this paper
• Isolation and identification of 1α‐hydroxy‐3‐epi‐vitamin D3, a potent suppressor of parathyroid hormone secretion

  2005cited by this paper
• Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome.

  2005cited by this paper
• A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.

  2005cited by this paper
• Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts.

  2005cited by this paper
• Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

  2005cited by this paper
• Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients

  2005cited by this paper
• Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia.

  2004cited by this paper
• Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.

  2004cited by this paper
• Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial.

  2004cited by this paper
• Pancreatic cancer cells express 25-hydroxyvitamin D-1α-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3

  2004cited by this paper
• Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).

  2004cited by this paper
• Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3.

  2004cited by this paper
• Induction of Ovarian Cancer Cell Apoptosis by 1,25-Dihydroxyvitamin D3 through the Down-regulation of Telomerase*

  2004cited by this paper
• Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo

  2004cited by this paper
• Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.

  2004cited by this paper
• 1,25-(OH)2-16ene-23yne-D3 Reduces Secondary Hyperparathyroidism in Uremic Rats with Little Calcemic Effect

  2004cited by this paper
• The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.

  2004cited by this paper
• Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl.

  2004cited by this paper
• Dose‐response Study of 22‐Oxacalcitriol in Patients with Secondary Hyperparathyroidism

  2004cited by this paper
• Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.

  2004cited by this paper
• Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism.

  2004cited by this paper
• A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.

  2004cited by this paper
• Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes

  2004cited by this paper
• Membrane receptors for vitamin D steroid hormones: potential new drug targets.

  2003cited by this paper
• DISPOSITION AND METABOLISM OF F6-1α,25(OH)2 VITAMIN D3 AND 1α,25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDS

  2003cited by this paper
• Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.

  2003cited by this paper
• Analogs of 1α,25‐dihydroxyvitamin D3 as pluripotent immunomodulators

  2003cited by this paper
• Disposition and metabolism of F6-1alpha,25(OH)2 vitamin D3 and 1alpha,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds.

  2003cited by this paper
• Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.

  2003cited by this paper
• Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.

  2003cited by this paper
• Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.

  2003cited by this paper
• Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.

  2003cited by this paper
• The Effects of 1α,25‐Dihydroxyvitamin D3 on the Expression of DNA Replication Genes

  2003cited by this paper
• Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.

  2003cited by this paper
• Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

  2003cited by this paper
• A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice

  2002cited by this paper
• Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.

  2002cited by this paper
• Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.

  2002cited by this paper
• A potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation

  2002cited by this paper
• A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action.

  2002cited by this paper

• Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy.

  2025cites this paper
• Diversity-Oriented Synthesis (DOS) Towards Calcitriol Analogs with Sulfur-Containing Side Chains

  2025cites this paper
• Synthesis and Evaluation of Aromatic A-Ring 23-Oxavitamin D3 Analogues as Hedgehog Pathway Inhibitors

  2025influential citation
• The Effects of Antioxidant Approved Drugs and Under Investigation Compounds with Potential of Improving Sleep Disorders and their Associated Comorbidities associated with Oxidative Stress and Inflammation.

  2025cites this paper
• Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies

  2024cites this paper
• Antiviral activity of vitamin D derivatives against severe fever with thrombocytopenia syndrome virus in vitro and in vivo

  2024cites this paper
• Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders

  2024cites this paper
• Vitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease?

  2024cites this paper
• The Role of Vitamin D in Sleep Disorders of Children and Adolescents: A Systematic Review

  2022cites this paper
• Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis.

  2022cites this paper
• Comparing the Effect of Different Doses of Vitamin D Supplementation During Pregnancy on Prevention of Adverse Pregnancy Outcomes; a Randomized Clinical Trial

  2022cites this paper
• Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters

  2022cites this paper
• Severe skeletal disability and abnormal biochemical tests & disease review

  2022cites this paper
• Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits

  2021cites this paper
• Vitamin D Promotes Skeletal Muscle Regeneration and Mitochondrial Health

  2021cites this paper
• Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy

  2021cites this paper
• The effect of vitamin D supplementation on tobacco-related disorders in individuals with a tobacco use disorder: a randomized clinical trial

  2021cites this paper
• Oral Vitamin D Therapy in Patients with Psoriasis

  2021cites this paper
• Metastatic and pathophysiological characteristics of breast cancer with emphasis on hereditary factors

  2021cites this paper
• Vitamin D and its analogs as anticancer and anti-inflammatory agents.

  2020cites this paper
• A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia

  2020cites this paper
• Vitamin D3 attenuates lipopolysaccharide-induced cognitive impairment in rats by inhibiting inflammation and oxidative stress.

  2020cites this paper
• Vitamin D receptor exhibits different pharmacodynamic features in tumoral and normal microenvironments: a molecular modeling study.

  2020cites this paper
• A Review on Potential Properties and Therapeutic Applications of Vitamin D

  2020cites this paper
• Relation between Crystal Structures of Precursors and Final Products: Example of Vitamin D Intermediates

  2020cites this paper
• Clinical Severity and Calcium Metabolism in Patients with Bipolar Disorder

  2020cites this paper
• Structure-Activity Relationship Study of an Alkynylphosphonate and a Vynilphosphonate Analogues of Calcitriol.

  2020cites this paper
• Potential effect of one-alpha-hydroxy vitamin D3 (alfacalcidol) on experimentally induced allergic asthma

  2020cites this paper
• Synthesis of 1α,25-dihydroxyvitamin D3 analogues with α,α-difluorocycloketone at the CD-ring side chains and their biological properties in ovariectomized rats.

  2019cites this paper
• Investigating the Role of VDR and Megalin in Semi-Selectivity of Side-Chain Modified 19-nor Analogs of Vitamin D

  2019cites this paper
• Toxicological evaluation of ergocalciferol, cholecalciferol, and their metabolites by a category approach

  2019cites this paper
• The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials.

  2019cites this paper
• Stereoselective Synthesis of Four Calcitriol Lactone Diastereomers at C23 and C25.

  2019cites this paper
• The effect of vitamin D supplementation on oxidative stress parameters: A systematic review and meta‐analysis of clinical trials

  2019cites this paper
• Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review

  2018cites this paper
• Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 by CYP24A1 and biological activity of its 24R-hydroxylated metabolite.

  2018cites this paper
• Analytical Aspects of Vitamin D

  2018cites this paper
• Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity.

  2018cites this paper
• Nrf2 Expression in CML and AML Patients’ Peripheral Blood Mononuclear Cells Treated by Vitamin D, Carnosic Acid and Curcumin

  2018cites this paper
• Antitumoral effects of the alkynylphosphonate analogue of calcitriol EM1 on glioblastoma multiforme cells.

  2017cites this paper
• Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre‐miR‐21 and VEGF

  2017cites this paper
• Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D3 analogues.

  2017cites this paper
• Proinflammatory Cytokines Impair Vitamin D‐Induced Host Defense in Cultured Airway Epithelial Cells

  2017cites this paper
• Improved accuracy of an tandem liquid chromatography-mass spectrometry method measuring 24R,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D metabolites in serum using unspiked controls and its application to determining cross-reactivity of a chemiluminescent microparticle immunoassay.

  2017cites this paper
• Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.

  2016cites this paper
• Vitamin D supplementation for osteoporosis in older adults: can we make it help better?

  2016cites this paper
• Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects

  2016cites this paper
• Analysis of vitamin D metabolites by liquid chromatography-tandem mass spectrometry

  2016cites this paper
• Vitamin D in the skin physiology and pathology.

  2016cites this paper
• Vitamin D Receptor (VDR) and Cholesterol Homeostasis: Interplay of VDR Enzyme Targets and Vitamin D Deficiency

  2016cites this paper
• Association of vitamin D deficiency with hepatitis B virus - related liver diseases

  2016cites this paper
• Novel 9-Alkyl- and 9-Alkylidene-Substituted 1α,25-Dihydroxyvitamin D3 Analogues: Synthesis and Biological Examinations.

  2015cites this paper
• Synthetic DAF-12 modulators with potential use in controlling the nematode life cycle.

  2015cites this paper
• Vitamin D Analogue: Potent Antiproliferative Effects on Cancer Cell Lines and Lack of Hypercalcemic Activity

  2015cites this paper
• Vitamin D in cancer chemoprevention

  2015cites this paper
• 19-Norvitamin D analogs for breast cancer therapy.

  2015cites this paper
• The role of vitamin D in cancer prevention.

  2015cites this paper
• Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture

  2015cites this paper
• A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues

  2015influential citation
• Inhibition of breast cancer progression with Vitamin D compounds

  2015cites this paper
• Antiproliferative Activity and in Vivo Toxicity of Double-Point Modified Analogs of 1,25-Dihydroxyergocalciferol

  2015cites this paper
• 26-Desmethyl-2-methylene-22-ene-19-nor-1α,25-dihydroxyvitamin D3 compounds selectively active on intestine.

  2014cites this paper
• Comparative metabolomics reveals endogenous ligands of DAF-12, a nuclear hormone receptor, regulating C. elegans development and lifespan.

  2014cites this paper
• Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17.

  2014cites this paper
• The Application of the Open Pharmacological Concepts Triple Store (Open PHACTS) to Support Drug Discovery Research

  2014cites this paper
• Perspectives of Differentiation Therapies of Acute Myeloid Leukemia: The Search for the Molecular Basis of Patients’ Variable Responses to 1,25-Dihydroxyvitamin D and Vitamin D Analogs

  2014cites this paper
• Vitamin D in Renal Transplantation – from Biological Mechanisms to Clinical Benefits

  2014cites this paper
• Vitamin D metabolism, mechanism of action, and clinical applications.

  2014cites this paper
• Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3.

  2014cites this paper
• Stereoselective reduction of C-20 ketone of vitamin D CD-ring and a new synthetic approach to maxacalcitol.

  2014cites this paper
• Improved and efficient synthesis of Maxacalcitol

  2014cites this paper
• A photocleavable masked nuclear-receptor ligand enables temporal control of C. elegans development.

  2014cites this paper
• Inflammation and vitamin D

  2013cites this paper
• Studying the calcium serum level in patients suffering from psoriasis.

  2013cites this paper
• Negativation of type 1 diabetes‐associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol (口服骨化三醇治疗维持儿童1型糖尿病相关的谷氨酸脱羧酶与胰岛素自身抗体阴性)

  2013cites this paper
• A lentiviral vector‐based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin

  2013cites this paper
• Vitamin D

  2013cites this paper
• Vitamin D and hyperparathyroidism in patients with chronic kidney disease

  2013cites this paper
• Synthesis of vitamin D3 analogues with A-ring modifications to directly measure vitamin D levels in biological samples.

  2013cites this paper
• Intravenous Vitamin D Treatment in Hemodialysis Patients: Patterns of Use and Association with Fracture Risk

  2013cites this paper
• Flash sur les dérivés de la vitamine D

  2013cites this paper
• Anticancer steroids: linking natural and semi-synthetic compounds.

  2013cites this paper
• Cardiorenal Syndrome Type 4: Management

  2013cites this paper
• The role of mass spectrometry in the analysis of vitamin D compounds.

  2013cites this paper
• Simultaneous Determination of Clobetasol Propionate and Calcipotriol in a Novel Fixed Dose Emulgel Formulation by LC-UV

  2013cites this paper
• Vitamin D and metabolites measurement by tandem mass spectrometry

  2013cites this paper
• 26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25-dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo.

  2013cites this paper
• Synthesis of 1α,25-dihydroxyvitamin D3 analogues with α-hydroxyalkyl substituents at C12.

  2013cites this paper
• Synthesis of 2‐Ethyl‐19‐nor Analogs of 1α,25‐Dihydroxyvitamin D3

  2013cites this paper
• Recent Developments of 19‐Nor‐1,25‐dihydroxyvitamin D3 Analogues

  2013cites this paper
• New vitamin D analogs as potential therapeutics in melanoma

  2012cites this paper
• Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability

  2012cites this paper
• Synthesis and biological activities of 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D(3) and their metabolism by human CYP24A1 and UDP-glucuronosyltransferase.

  2012cites this paper
• Design, synthesis, evaluation, and structure of vitamin D analogues with furan side chains.

  2012cites this paper
• Diversity and substrate specificity in the structures of steroidogenic cytochrome P450 enzymes.

  2012cites this paper
• Potent 19-norvitamin D analogs for prostate and liver cancer therapy.

  2012cites this paper
• Vitamin D and the kidney.

  2012cites this paper
• Assessment of the free binding energy of 1,25-dihydroxyvitamin D3 and its analogs with the human VDR receptor model.

  2012cites this paper
• Vitamin D in ulcerative colitis: A cause or an effect?

  2012cites this paper
• Immunomodulation using agonists and antagonists: potential clinical applications

  2012cites this paper